U.S., Oct. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07206615) titled 'Spot Ex PMCF 01 Study' on Sept. 26.
Brief Summary: Post market clinical study that is a chart review of the Spot Ex Endoscopic Marker
Study Start Date: Oct., 2025
Study Type: OBSERVATIONAL
Condition: 
Presence of Spot Ex Endoscopic Marker
Intervention: 
OTHER: Endoscopic marker
Study to confirm the safety and performance of the Laborie Spot Ex Endoscopic Marker in accordance with the approved labelling/instructions for use (IFU).
Recruitment Status: ENROLLING_BY_INVITATION
Sponsor: Laborie Medical Technologies Inc.
Published by HT Digital Content Services with permission from Health Daily Digest....